Production of influenza virus complement-fixing antibody in mouse ascitic fluid.

Journal of Clinical Microbiology
L A WhiteW A Chappell

Abstract

Suspension cultures of BHK-21/13s cells infected with either A/Hong Kong/8/68 or B/Massachusetts/3/66 strains of influenza were used to prepare type-specific influenza ribonucleoprotein-immunizing antigens. These antigens were used in comparing four immunization schedules in the production of immune mouse ascitic fluids. Large volumes of ascitic fluids were obtained by these schedules. These fluids contained type-specific complement-fixing antibody and were devoid of nonspecific host tissue or heterologous cross-reactions.

References

May 1, 1967·The American Journal of Tropical Medicine and Hygiene·W E BrandtF M Hetrick
Sep 1, 1972·Applied Microbiology·J C HierholzerW A Chappell
Mar 1, 1966·The American Journal of Tropical Medicine and Hygiene·E S TikasinghW G Downs
Jun 1, 1958·Proceedings of the Society for Experimental Biology and Medicine·E C HERRMANN, C ENGLE
Jun 1, 1960·Proceedings of the Society for Experimental Biology and Medicine·M A BUCCAJ F WINN
Oct 1, 1962·Proceedings of the Society for Experimental Biology and Medicine·S BERKOVICH
Dec 1, 1959·Virology·J A KASELH A SMITH

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.